Affimed N.V.

Affimed N.V.https://investorshangout.com/Affimed-NV-AFMD-90975/en-usThu, 05 Nov 2026 13:40:23 GMTCopyright InvestorsHangout.comwhytestocks: $AFMD News Article - Affimed Provides Clinical Response Update on AFM24-102 Trial in EGFR-wildtype Nhttps://investorshangout.com/post/view?id=6661250https://investorshangout.com/post/view?id=6661250Mon, 08 Jan 2024 21:15:51 GMTwhytestocks: $AFMD News Article - Affimed Announces Leadership Change and Organizational Restructuring https://investorshangout.com/post/view?id=6660961https://investorshangout.com/post/view?id=6660961Mon, 08 Jan 2024 13:20:49 GMTwhytestocks: $AFMD News Article - Affimed Announces Publication in the Journal mAbs on Leveraging FcRn-pH-HPLC ashttps://investorshangout.com/post/view?id=6610873https://investorshangout.com/post/view?id=6610873Tue, 22 Aug 2023 14:40:46 GMTwhytestocks: $AFMD News Article - Affimed Announces Abstracts at the Annual Meeting of the European Hematology Ashttps://investorshangout.com/post/view?id=6573713https://investorshangout.com/post/view?id=6573713Thu, 11 May 2023 18:05:49 GMTznewcar1: $AFMD Hod.9269 F149.34M ML.66 off LL.55 RH10+24 +5.53% 676,459 .870900 149,339,335 +5.53% .926900 https://investorshangout.com/post/view?id=6566363https://investorshangout.com/post/view?id=6566363Tue, 25 Apr 2023 17:06:53 GMTwhytestocks: $AFMD News Article - Affimed Shares Preclinical Data on AFM13's Mechanism of Action Demonstrating Ithttps://investorshangout.com/post/view?id=6562295https://investorshangout.com/post/view?id=6562295Mon, 17 Apr 2023 20:15:49 GMTwhytestocks: $AFMD News Article - Affimed Announces First Patient Successfully Dosed in the First-in-Human Study https://investorshangout.com/post/view?id=6554224https://investorshangout.com/post/view?id=6554224Wed, 29 Mar 2023 14:20:58 GMTwhytestocks: $AFMD News Article - AbCheck Announces Successful Completion of Research and Development Under Granthttps://investorshangout.com/post/view?id=6546497https://investorshangout.com/post/view?id=6546497Thu, 09 Mar 2023 17:20:49 GMTwhytestocks: $AFMD News Article - Affimed Reports Third Quarter 2022 Financial Results and Highlights Recent Clinhttps://investorshangout.com/post/view?id=6498617https://investorshangout.com/post/view?id=6498617Tue, 15 Nov 2022 18:55:55 GMTznewcar1: $AFMD 22% v5,6M c2.39 f149M H2.48https://investorshangout.com/post/view?id=6495233https://investorshangout.com/post/view?id=6495233Tue, 08 Nov 2022 03:48:36 GMTwhytestocks: $AFMD News Article - Affimed Provides Data Update from Two Phase 1/2a Trials with its Innate Cell Enhttps://investorshangout.com/post/view?id=6494767https://investorshangout.com/post/view?id=6494767Mon, 07 Nov 2022 15:00:50 GMTwhytestocks: $AFMD News Article - Affimed to Report Third Quarter 2022 Financial Results & Corporate Update on Nohttps://investorshangout.com/post/view?id=6494114https://investorshangout.com/post/view?id=6494114Fri, 04 Nov 2022 15:40:53 GMTwhytestocks: $AFMD News Article - Affimed Announces Presentation of Phase 1/2 Data from AFM13 in Combination withhttps://investorshangout.com/post/view?id=6493439https://investorshangout.com/post/view?id=6493439Thu, 03 Nov 2022 13:50:48 GMTwhytestocks: $AFMD News Article - Affimed to Present at the 2022 Jefferies London Healthcare Conference https://investorshangout.com/post/view?id=6492519https://investorshangout.com/post/view?id=6492519Tue, 01 Nov 2022 17:46:02 GMTwhytestocks: $AFMD News Article - Why Affimed Stock Is Heating Up Today https://investorshangout.com/post/view?id=6381258https://investorshangout.com/post/view?id=6381258Mon, 11 Apr 2022 16:35:49 GMTwhytestocks: $AFMD News Article - Affimed Reports 2021 Financial Results and Highlights Recent Operational Progrehttps://investorshangout.com/post/view?id=6374293https://investorshangout.com/post/view?id=6374293Thu, 31 Mar 2022 15:20:54 GMTwhytestocks: $AFMD News Article - Affimed to Report Full Year 2021 Financial Results & Corporate Update on March https://investorshangout.com/post/view?id=6369319https://investorshangout.com/post/view?id=6369319Thu, 24 Mar 2022 14:19:47 GMTwhytestocks: $AFMD News Article - Affimed to Host Virtual Investor Call Today to Discuss Treatment of CD30-positihttps://investorshangout.com/post/view?id=6297811https://investorshangout.com/post/view?id=6297811Thu, 09 Dec 2021 13:31:09 GMTwhytestocks: $AFMD News Article - Why Affimed Stock Is On Fire Today https://investorshangout.com/post/view?id=6288177https://investorshangout.com/post/view?id=6288177Mon, 22 Nov 2021 19:35:49 GMTwhytestocks: $AFMD News Article - Affimed Announces 100% Objective Response Rate at Highest Dose in Phase 1-2 Stuhttps://investorshangout.com/post/view?id=6288129https://investorshangout.com/post/view?id=6288129Mon, 22 Nov 2021 18:50:51 GMTwhytestocks: $AFMD News Article - Affimed to Report Third Quarter 2021 Financial Results & Corporate Update on Nohttps://investorshangout.com/post/view?id=6273137https://investorshangout.com/post/view?id=6273137Fri, 29 Oct 2021 15:50:47 GMTwhytestocks: $AFMD News Article - Affimed to Report First Quarter 2021 Financial Results & Corporate Update July https://investorshangout.com/post/view?id=6165885https://investorshangout.com/post/view?id=6165885Tue, 22 Jun 2021 19:45:49 GMTwhytestocks: $AFMD News Article - Shares of Affimed N.V. (AFMD) Have Risen Above Previous 52-Week High https://investorshangout.com/post/view?id=6116540https://investorshangout.com/post/view?id=6116540Fri, 23 Apr 2021 18:10:51 GMTwhytestocks: $AFMD News Article - Here's Why Shares of Affimed Skyrocketed Today https://investorshangout.com/post/view?id=6104823https://investorshangout.com/post/view?id=6104823Fri, 09 Apr 2021 18:55:49 GMTwhytestocks: $AFMD News Article - Affimed N.V.: 52-Week High Recently Eclipsed (AFMD) https://investorshangout.com/post/view?id=6104666https://investorshangout.com/post/view?id=6104666Fri, 09 Apr 2021 16:55:46 GMTwhytestocks: $AFMD News Article - Affimed Announces Presentation at AACR Highlighting Initial Data from Phase 1 Shttps://investorshangout.com/post/view?id=6104350https://investorshangout.com/post/view?id=6104350Fri, 09 Apr 2021 13:55:48 GMTznewcar1: AFMD 23% v6,8M c6.77 f114M H7.35https://investorshangout.com/post/view?id=6080034https://investorshangout.com/post/view?id=6080034Wed, 10 Mar 2021 22:41:09 GMTwhytestocks: $AFMD News Article - Affimed Announces Continuation of REDIRECT, a Registration-directed Study of AFhttps://investorshangout.com/post/view?id=6079463https://investorshangout.com/post/view?id=6079463Wed, 10 Mar 2021 15:40:49 GMTwhytestocks: $AFMD News Article - Affimed Announces Pipeline and Business Update https://investorshangout.com/post/view?id=6011531https://investorshangout.com/post/view?id=6011531Thu, 07 Jan 2021 20:50:50 GMTznewcar1: AFMD 20% v7,1M c6.77 f88,3M H7.07 S6.63https://investorshangout.com/post/view?id=5983161https://investorshangout.com/post/view?id=5983161Tue, 08 Dec 2020 00:52:11 GMTwhytestocks: $AFMD News Article - Affimed Announces Updated AFM13 Clinical Data Presentation at the American Socihttps://investorshangout.com/post/view?id=5982529https://investorshangout.com/post/view?id=5982529Mon, 07 Dec 2020 16:05:47 GMTwhytestocks: $AFMD News Article - Affimed Announces Publication of Final Study Results of its Innate Cell Engagerhttps://investorshangout.com/post/view?id=5968213https://investorshangout.com/post/view?id=5968213Thu, 19 Nov 2020 21:40:54 GMTwhytestocks: $AFMD News Article - Affimed N.V. (AFMD) Q3 2020 Earnings Call Transcript https://investorshangout.com/post/view?id=5958004https://investorshangout.com/post/view?id=5958004Tue, 10 Nov 2020 19:40:47 GMTwhytestocks: $AFMD News Article - 4 Penny Stocks To Buy According To These Analysts; Do You Agree? https://investorshangout.com/post/view?id=5957818https://investorshangout.com/post/view?id=5957818Tue, 10 Nov 2020 17:40:47 GMTwhytestocks: $AFMD News Article - AbCheck s.r.o. Receives Grant to Further Develop a Discovery Technology for Funhttps://investorshangout.com/post/view?id=5919691https://investorshangout.com/post/view?id=5919691Tue, 06 Oct 2020 12:10:52 GMTwhytestocks: $AFMD News Article - Affimed to Present at Jefferies Virtual Cell Therapy Summit https://investorshangout.com/post/view?id=5912071https://investorshangout.com/post/view?id=5912071Tue, 29 Sep 2020 19:15:49 GMTwhytestocks: $AFMD News Article - Affimed Reports First Quarter 2020 Financial Results and Operational Progress https://investorshangout.com/post/view?id=5803084https://investorshangout.com/post/view?id=5803084Tue, 23 Jun 2020 12:10:49 GMTwhytestocks: $AFMD News Article - Affimed Announces Successful Completion of First Dose Cohort in First-in-Human https://investorshangout.com/post/view?id=5797844https://investorshangout.com/post/view?id=5797844Wed, 17 Jun 2020 12:30:43 GMTwhytestocks: $AFMD News Article - Affimed to Report First Quarter 2020 Financial Results & Corporate Update June https://investorshangout.com/post/view?id=5796718https://investorshangout.com/post/view?id=5796718Tue, 16 Jun 2020 12:25:47 GMTwhytestocks: $AFMD News Article - Affimed Announces Third Quarter 2019 Financial Results and Corporate Update Conhttps://investorshangout.com/post/view?id=5592167https://investorshangout.com/post/view?id=5592167Thu, 14 Nov 2019 16:20:45 GMTwhytestocks: $AFMD News Article - Affimed to Present at the Jefferies 2019 London Healthcare Conference https://investorshangout.com/post/view?id=5592160https://investorshangout.com/post/view?id=5592160Thu, 14 Nov 2019 16:15:44 GMTwhytestocks: $AFMD News Article - Affimed Added to the Russell 2000 , 3000 and Microcap Indexes https://investorshangout.com/post/view?id=5474208https://investorshangout.com/post/view?id=5474208Mon, 01 Jul 2019 16:40:42 GMTHattlem: Affimed Therapeutics enters into collaboration with MerckAffimed (AFMD) announced that it has enterehttps://investorshangout.com/post/view?id=3502597https://investorshangout.com/post/view?id=3502597Mon, 25 Jan 2016 14:49:06 GMTdanrocks: AFMD Stock is number 115 for the largest percentage gain out of 250 stocks. $AFMD AFMD is up +14.https://investorshangout.com/post/view?id=3431334https://investorshangout.com/post/view?id=3431334Sat, 19 Dec 2015 03:09:05 GMT